Skip to main content
Top
Published in: Endocrine 2/2016

01-02-2016 | Original Article

Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus

Authors: Ali Khosrowbeygi, Najmeh Shiamizadeh, Nima Taghizadeh

Published in: Endocrine | Issue 2/2016

Login to get access

Abstract

The aims of the present study were to explore serum levels of lipid profile, atherogenic indexes LDL-C/HDL-C, TG/HDL-C, and TC/HDL-C, bilirubin, adiponectin, pseudocholinesterase, activities of gamma-glutamyltransferase (GGT), adenosine deaminase (ADA), and α-amylase, insulin resistance using homeostasis model assessment of insulin resistance (HOMA-IR) formula, and assessment of correlations between them in gestational diabetes mellitus (GDM) compared with normal pregnancy. A cross-sectional study was designed. The patients consisted of 30 women with GDM. The normal group consisted of 30 healthy pregnant women. The Mann–Whitney U test and Spearman’s correlation analysis were used for statistical analysis. A p value less than 0.05 was considered significant. Serum activities of enzymes GGT (p = 0.001) and ADA (p = 0.02) were significantly higher in GDM compared with normal pregnancy, while pseudocholinesterase were significantly decreased (p = 0.02). However, activity of enzyme α-amylase did not show significant difference between two groups (p = 0.75). Serum levels of both HDL-C and adiponectin were significantly decreased in GDM group (p = 0.001). The atherogenic indexes and the HOMA-IR index were significantly higher in GDM (p = 0.001). Serum activity of ADA showed positive correlation with total cholesterol (TC) (r = 0.46, p = 0.01) and CRP (r = 0.66, p = 0.001) in GDM group. Serum levels of total bilirubin correlated negatively with both ADA (r = −0.38, p = 0.04) and triglyceride (r = −0.45, p = 0.01) in women with GDM. Serum activity of GGT correlated positively with LDL-C (r = 0.48, p = 0.01) and TC (r = 0.52, p = 0.003) in GDM group. Increased atherogenic indexes, ADA, GGT, and decreased pseudocholinesterase might be risk factors for GDM.
Literature
1.
go back to reference M. Aslan, O. Celik, N. Celik, I. Turkcuoglu, E. Yilmaz, A. Karaer, Y. Simsek, E. Celik, S. Aydin, Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 41, 424–429 (2012)CrossRefPubMed M. Aslan, O. Celik, N. Celik, I. Turkcuoglu, E. Yilmaz, A. Karaer, Y. Simsek, E. Celik, S. Aydin, Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 41, 424–429 (2012)CrossRefPubMed
2.
go back to reference M.I. Yeral, A.S. Ozgu-Erdinc, D. Uygur, K.D. Seckin, M.F. Karsli, A.N. Danisman, Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46, 512–518 (2014)CrossRefPubMed M.I. Yeral, A.S. Ozgu-Erdinc, D. Uygur, K.D. Seckin, M.F. Karsli, A.N. Danisman, Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46, 512–518 (2014)CrossRefPubMed
3.
go back to reference J.G. Lee, S.W. Park, B.M. Cho, S. Lee, Y.J. Kim, D.W. Jeong, Y.H. Yi, Y.H. Cho, Serum amylase and risk of the metabolic syndrome in Korean adults. Clin. Chim. Acta 412, 1848–1853 (2011)CrossRefPubMed J.G. Lee, S.W. Park, B.M. Cho, S. Lee, Y.J. Kim, D.W. Jeong, Y.H. Yi, Y.H. Cho, Serum amylase and risk of the metabolic syndrome in Korean adults. Clin. Chim. Acta 412, 1848–1853 (2011)CrossRefPubMed
5.
go back to reference Y. Zhao, J. Zhang, J. Zhang, J. Wu, Y. Chen, Metabolic syndrome and diabetes are associated with low serum amylase in a Chinese asymptomatic population. Scand. J. Clin. Lab. Invest. 74, 235–239 (2014)CrossRefPubMed Y. Zhao, J. Zhang, J. Zhang, J. Wu, Y. Chen, Metabolic syndrome and diabetes are associated with low serum amylase in a Chinese asymptomatic population. Scand. J. Clin. Lab. Invest. 74, 235–239 (2014)CrossRefPubMed
7.
go back to reference K. Ryckman, C. Spracklen, C. Smith, J. Robinson, A. Saftlas, Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 122, 643–651 (2015)CrossRefPubMed K. Ryckman, C. Spracklen, C. Smith, J. Robinson, A. Saftlas, Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 122, 643–651 (2015)CrossRefPubMed
8.
go back to reference P.C. Tan, S. Mubarak, S.Z. Omar, Gamma-glutamyltransferase level in pregnancy is an independent risk factor for gestational diabetes mellitus. J. Obstet. Gynaecol. Res. 34, 512–517 (2008)CrossRefPubMed P.C. Tan, S. Mubarak, S.Z. Omar, Gamma-glutamyltransferase level in pregnancy is an independent risk factor for gestational diabetes mellitus. J. Obstet. Gynaecol. Res. 34, 512–517 (2008)CrossRefPubMed
9.
go back to reference I. Alanbay, H. Coksuer, M. Ercan, U. Keskin, E. Karasahin, M. Ozturk, S. Tapan, O. Ozturk, I. Kurt, A. Ergun, Can serum gamma-glutamyltransferase levels be useful at diagnosing gestational diabetes mellitus? Gynecol. Endocrinol. 28, 208–211 (2012)CrossRefPubMed I. Alanbay, H. Coksuer, M. Ercan, U. Keskin, E. Karasahin, M. Ozturk, S. Tapan, O. Ozturk, I. Kurt, A. Ergun, Can serum gamma-glutamyltransferase levels be useful at diagnosing gestational diabetes mellitus? Gynecol. Endocrinol. 28, 208–211 (2012)CrossRefPubMed
10.
go back to reference P.C. Tan, A.Z. Aziz, I.S. Ismail, S.Z. Omar, Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus. Clin. Biochem. 45, 1192–1196 (2012)CrossRefPubMed P.C. Tan, A.Z. Aziz, I.S. Ismail, S.Z. Omar, Gamma-glutamyltransferase, alanine transaminase and aspartate transaminase levels and the diagnosis of gestational diabetes mellitus. Clin. Biochem. 45, 1192–1196 (2012)CrossRefPubMed
11.
12.
go back to reference M.G. Gohel, A.N. Chacko, Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: an evidence linking oxidative stress, inflammation and glycemic control. J. Diabetes Metab. Disord. 12, 56 (2013)CrossRefPubMedPubMedCentral M.G. Gohel, A.N. Chacko, Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: an evidence linking oxidative stress, inflammation and glycemic control. J. Diabetes Metab. Disord. 12, 56 (2013)CrossRefPubMedPubMedCentral
14.
go back to reference A. Sunto, K. Mochizuki, R. Miyauchi, Y. Misaki, M. Shimada, N. Kasezawa, K. Tohyama, T. Goda, Serum γ-GTP activity is closely associated with serum CRP levels in non-overweight and overweight middle-aged Japanese men. J. Nutr. Sci. Vitaminol (Tokyo) 59, 108–114 (2013)CrossRef A. Sunto, K. Mochizuki, R. Miyauchi, Y. Misaki, M. Shimada, N. Kasezawa, K. Tohyama, T. Goda, Serum γ-GTP activity is closely associated with serum CRP levels in non-overweight and overweight middle-aged Japanese men. J. Nutr. Sci. Vitaminol (Tokyo) 59, 108–114 (2013)CrossRef
15.
go back to reference K.S. De Bona, G. Bonfanti, P.E. Bitencourt, L.O. Cargnelutti, P.S. da Silva, L. De Lucca, V.C. Pimentel, E. Tatsch, T.L. Gonçalves, M. Premaor, R.N. Moresco, M.B. Moretto, Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index. Inflammation 36, 1539–1547 (2013)CrossRefPubMed K.S. De Bona, G. Bonfanti, P.E. Bitencourt, L.O. Cargnelutti, P.S. da Silva, L. De Lucca, V.C. Pimentel, E. Tatsch, T.L. Gonçalves, M. Premaor, R.N. Moresco, M.B. Moretto, Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index. Inflammation 36, 1539–1547 (2013)CrossRefPubMed
16.
go back to reference N.G. Vallianou, A.A. Evangelopoulos, V. Bountziouka, M.S. Bonou, C. Katsagoni, E.D. Vogiatzakis, P.C. Avgerinos, J. Barbetseas, D.B. Panagiotakos, Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults. J. Cardiovasc. Med. (Hagerstown) 15, 377–383 (2014)CrossRef N.G. Vallianou, A.A. Evangelopoulos, V. Bountziouka, M.S. Bonou, C. Katsagoni, E.D. Vogiatzakis, P.C. Avgerinos, J. Barbetseas, D.B. Panagiotakos, Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults. J. Cardiovasc. Med. (Hagerstown) 15, 377–383 (2014)CrossRef
17.
go back to reference L.P. Cocelli, E. Dikensoy, H. Cicek, Y. Ibar, S. Kul, O. Balat, Pseudocholinesterase in gestational diabetes: positive correlation with LDL and negative correlation with triglyceride. Arch. Gynecol. Obstet. 286, 43–49 (2012)CrossRefPubMed L.P. Cocelli, E. Dikensoy, H. Cicek, Y. Ibar, S. Kul, O. Balat, Pseudocholinesterase in gestational diabetes: positive correlation with LDL and negative correlation with triglyceride. Arch. Gynecol. Obstet. 286, 43–49 (2012)CrossRefPubMed
18.
go back to reference L.O. Guimarães, F.A. de Andrade, G.F. Bono, T.E. Setoguchi, M.B. Brandão, E.A. Chautard-Freire-Maia, I.C. Dos Santos, G. Picheth, A.C. Faria, R.R. Réa, R.L. Souza, L. Furtado-Alle, Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids. Genet. Mol. Biol. 37, 1–6 (2014)CrossRefPubMedPubMedCentral L.O. Guimarães, F.A. de Andrade, G.F. Bono, T.E. Setoguchi, M.B. Brandão, E.A. Chautard-Freire-Maia, I.C. Dos Santos, G. Picheth, A.C. Faria, R.R. Réa, R.L. Souza, L. Furtado-Alle, Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids. Genet. Mol. Biol. 37, 1–6 (2014)CrossRefPubMedPubMedCentral
19.
go back to reference R. Wang, G. Yang, Z. Lyu, J. Dou, W. Gu, L. Zang, N. Jin, J. Du, J. Ouyang, Q. Guo, X. Wang, L. Yang, J. Ba, Y. Mu, A correlation study between serum direct bilirubin and lipid in type 2 diabetic patients. Zhonghua. Nei. Ke. Za. Zhi. 53, 783–787 (2014)PubMed R. Wang, G. Yang, Z. Lyu, J. Dou, W. Gu, L. Zang, N. Jin, J. Du, J. Ouyang, Q. Guo, X. Wang, L. Yang, J. Ba, Y. Mu, A correlation study between serum direct bilirubin and lipid in type 2 diabetic patients. Zhonghua. Nei. Ke. Za. Zhi. 53, 783–787 (2014)PubMed
20.
go back to reference M. Mokhtari, M. Hashemi, M. Yaghmaei, F. Molashahi, A. Shikhzadeh, A. Niazi, S. Ghavami, Serum adenosine deaminase activity in gestational diabetes mellitus and normal pregnancy. Arch. Gynecol. Obstet. 281, 623–626 (2010)CrossRefPubMed M. Mokhtari, M. Hashemi, M. Yaghmaei, F. Molashahi, A. Shikhzadeh, A. Niazi, S. Ghavami, Serum adenosine deaminase activity in gestational diabetes mellitus and normal pregnancy. Arch. Gynecol. Obstet. 281, 623–626 (2010)CrossRefPubMed
21.
go back to reference C.J. Homko, New recommendations for the diagnosis of diabetes in pregnancy. Curr. Diabetes Rep. 11, 1–3 (2011)CrossRef C.J. Homko, New recommendations for the diagnosis of diabetes in pregnancy. Curr. Diabetes Rep. 11, 1–3 (2011)CrossRef
22.
go back to reference W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–503 (1972)PubMed W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–503 (1972)PubMed
24.
go back to reference D. Wang, S. Xu, H. Chen, L. Zhong, Z. Wang, The associations between triglyceride to high-density lipoprotein cholesterol ratios and the risks of gestational diabetes mellitus and large-for-gestational-age infant. Clin. Endocrinol. (Oxf) (2015). doi:10.1111/cen.12742 PubMed D. Wang, S. Xu, H. Chen, L. Zhong, Z. Wang, The associations between triglyceride to high-density lipoprotein cholesterol ratios and the risks of gestational diabetes mellitus and large-for-gestational-age infant. Clin. Endocrinol. (Oxf) (2015). doi:10.​1111/​cen.​12742 PubMed
25.
go back to reference X. Jia, S. Wang, N. Ma, X. Li, L. Guo, X. Liu, T. Dong, Y. Liu, Q. Lu, Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women. Endocrine 48, 533–540 (2015)CrossRefPubMed X. Jia, S. Wang, N. Ma, X. Li, L. Guo, X. Liu, T. Dong, Y. Liu, Q. Lu, Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women. Endocrine 48, 533–540 (2015)CrossRefPubMed
26.
go back to reference S.M. Li, W.F. Wang, L.H. Zhou, L. Ma, Y. An, W.J. Xu, T.H. Li, Y.H. Yu, D.S. Li, Y. Liu, Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum. Endocrine 48, 519–527 (2015)CrossRefPubMed S.M. Li, W.F. Wang, L.H. Zhou, L. Ma, Y. An, W.J. Xu, T.H. Li, Y.H. Yu, D.S. Li, Y. Liu, Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum. Endocrine 48, 519–527 (2015)CrossRefPubMed
27.
go back to reference E.M. Akbas, A. Timuroglu, A. Ozcicek, F. Ozcicek, L. Demirtas, A. Gungor, N. Akbas, Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus. Int. J. Clin. Exp. Med. 7, 5737–5743 (2014)PubMedPubMedCentral E.M. Akbas, A. Timuroglu, A. Ozcicek, F. Ozcicek, L. Demirtas, A. Gungor, N. Akbas, Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus. Int. J. Clin. Exp. Med. 7, 5737–5743 (2014)PubMedPubMedCentral
28.
go back to reference E. Oda, Cross-sectional and longitudinal associations between serum bilirubin and dyslipidemia in a health screening population. Atherosclerosis 239, 31–37 (2015)CrossRefPubMed E. Oda, Cross-sectional and longitudinal associations between serum bilirubin and dyslipidemia in a health screening population. Atherosclerosis 239, 31–37 (2015)CrossRefPubMed
29.
go back to reference Y.G. Sargisova, N.A. Andreasyan, H.L. Hayrapetyan, H.A. Harutyunyan, Nitric oxide—an activating factor of adenosine deaminase 2 in vitro. Biochemistry (Mosc) 77, 92–97 (2012)CrossRef Y.G. Sargisova, N.A. Andreasyan, H.L. Hayrapetyan, H.A. Harutyunyan, Nitric oxide—an activating factor of adenosine deaminase 2 in vitro. Biochemistry (Mosc) 77, 92–97 (2012)CrossRef
31.
go back to reference L. Tao, E. Gao, X. Jiao, Y. Yuan, S. Li, T.A. Christopher, B.L. Lopez, W. Koch, L. Chan, B.J. Goldstein, X.L. Ma, Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115, 1408–1416 (2007)CrossRefPubMed L. Tao, E. Gao, X. Jiao, Y. Yuan, S. Li, T.A. Christopher, B.L. Lopez, W. Koch, L. Chan, B.J. Goldstein, X.L. Ma, Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115, 1408–1416 (2007)CrossRefPubMed
32.
go back to reference A. Khosrowbeygi, H. Ahmadvand, Positive correlation between serum levels of adiponectin and homocysteine in pre-eclampsia. J. Obstet. Gynaecol. Res. 39, 641–646 (2013)CrossRefPubMed A. Khosrowbeygi, H. Ahmadvand, Positive correlation between serum levels of adiponectin and homocysteine in pre-eclampsia. J. Obstet. Gynaecol. Res. 39, 641–646 (2013)CrossRefPubMed
33.
go back to reference R. Yao, Y. Zhou, Y. He, Y. Jiang, P. Liu, L. Ye, Z. Zheng, W.B. Lau, Y. Cao, Z. Zeng, Adiponectin protects against paraquat-induced lung injury by attenuating oxidative/nitrative stress. Exp. Ther. Med. 9, 131–136 (2015)PubMedPubMedCentral R. Yao, Y. Zhou, Y. He, Y. Jiang, P. Liu, L. Ye, Z. Zheng, W.B. Lau, Y. Cao, Z. Zeng, Adiponectin protects against paraquat-induced lung injury by attenuating oxidative/nitrative stress. Exp. Ther. Med. 9, 131–136 (2015)PubMedPubMedCentral
Metadata
Title
Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus
Authors
Ali Khosrowbeygi
Najmeh Shiamizadeh
Nima Taghizadeh
Publication date
01-02-2016
Publisher
Springer US
Published in
Endocrine / Issue 2/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0697-4

Other articles of this Issue 2/2016

Endocrine 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.